This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis

Clive Ballard, MBChB, MMedSci, MRCPsych, MDa

Published: April 27, 2021

Atypical antipsychotics play a limited role in the management of dementia-related psychosis (DRP). Major adverse outcomes are associated with most antipsychotics in patients with dementia, and guidelines recommend that these drugs not be prescribed for long durations. When treating symptoms of DRP, clinicians should follow guidelines such as using medication only if the patient or others are in distress or danger and starting with low doses. Novel antipsychotics or alternative agents may offer superior efficacy and safety.

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

To read more on the subject, visit the related Academic Highlights

To cite: Ballard C. Evidence-based treatment and monitoring strategies for dementia-related psychosis. J Clin Psychiatry. 2021;82(3):AD19038BR4C.
To share:
© Copyright 2021 Physicians Postgraduate Press, Inc.
aUniversity of Exeter College of Medicine and Health, UK


Volume: 82

Quick Links: